Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Evolution of Outcome over Time for Relapsed Hodgkin Lymphoma after Autologous Stem Cell Transplant: Improved Survival for Early Relapse in Recent Years

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-138546

Published: 2020

Journal Articles

Post-Transplant High-Dose Cyclophosphamide Overcomes the Detrimental Effect of a Single-Locus HLA Mismatched in Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Patricia Ferraz, MD, Arturo Pereira, MD PhD, María Suárez-Lledó, MD, Gonzalo Gutiérrez-García, MD, Francesc Fernández-Avilés, MD, Laura Rosinol, MD PhD, Teresa Solano, Noemí Llobet, Carla Ramos, Pedro Marín, MD, Alvaro Urbano-Ispizua, MD, Montserrat Rovira, MD, Carmen Martinez, MD PhD

Blood (2018) 132 (Supplement 1): 4576.

https://doi.org/10.1182/blood-2018-99-112985

Published: 2018

Journal Articles

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

Carmen Martinez, MD PhD, Cecilia Carpio, MD, Inmaculada Heras, Eduardo Ríos Herranz, MD, Joan Buch, Antonio Gutierrez, MD PhD, Samuel Romero, Izaskun Ceberio, Irene Garcia-Garcia, Antonia Rodriguez Izquierdo, PhD, Rosalia Alonso, Joan Bargay, MD PhD, Cristina Barrenetxea Lekue, PhD, Narvaez Javier, Manuel Espeso de Haro, MD, Luis Palomera, MD PhD, Ramon García-Sanz, MD PhD

Blood (2018) 132 (Supplement 1): 2936.

https://doi.org/10.1182/blood-2018-99-115774

Published: 2018

Journal Articles

Second Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma after a Previous Autograft: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Carmen Martinez, MD PhD, Ariane Boumendil, PhD, Joanna Romejko-Jarosinska, Achilles Anagnostopoulos, Edgar Faber, MD, Xavier Poire, MD, Ibrahim Yakoub-Agha, MD PhD, Saad Akhtar, MD, Gunhan Gurman, Vincenzo Pavone, Kazimierz Halaburda, Aida Botelho Sousa, Herv Ghesquieres, Hervé Finel, Irma Khvedelidze, Silvia Montoto, MD, Anna Sureda, MD

Blood (2018) 132 (Supplement 1): 3429.

https://doi.org/10.1182/blood-2018-99-112180

Published: 2018

Journal Articles

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Ramon Garcia-Sanz, MD PhD, Anna Sureda, MD PhD, Ana Pilar Gonzalez, MD, Fatima De la Cruz, MD PhD, Blanca Sanchez-Gonzalez, MD PhD, Antonia Rodriguez, MD PhD, Eva Domingo-Domenech, MD, Moreno Miriam, MD, Moreno Miriam, MD, Javier Lopez, Sr., MD PhD, Piñana Luis Jose, Gabriela Rodríguez, MD PhD, Miguel Canales, MD PhD, Antonio Gutierrez, MD PhD, Maria Dolores Caballero, MD PhD, Carmen Martinez, MD PhD

Blood (2016) 128 (22): 1109.

https://doi.org/10.1182/blood.V128.22.1109.1109

Published: 2016

Journal Articles

Evaluation of the Regimen Brentuximab Vedotin Plus ESHAP (BRESHAP) in Refractory or Relapsed Hodgkin Lymphoma Patients: Preliminary Results of a Phase I-II Trial from the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Ramon Garcia-Sanz, MDPhD, Anna Sureda, MD PhD, Sara Alonso-Alvarez, MD, Ana Pilar Gonzalez, MD, Antonia Rodriguez, MD PhD, Antonio Salar, MD PhD, Fatima de la Cruz, MD, Eva Domingo, MD, Miriam Moreno, MD, Javier Lopez, Sr., MD PhD, Jose Luis Piñana, MD, Gabriela Rodriguez, Miguel Canales, Antonio Manuel Gurierrez, MD, Armando López-Guillermo, MD, María Dolores Caballero, MD PhD, Silvia Jimenez, BsC, Carmen Martinez, MD PhD

Blood (2015) 126 (23): 582.

https://doi.org/10.1182/blood.V126.23.582.582

Published: 2015

Journal Articles

Association Between Uric Acid Levels and Severe Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation

Nuria Martinez-Cibrian, Teresa Garrido, Arturo Pereira, Mauricio Sarmiento, Jose Antonio Pérez-Simón, Rocio Parody, MD, Estefania Perez, Oriana Lopez, Carlos Solano, Jose Luis Piñana, Montserrat Rovira, Francesc Fernandez-Avilés, Maria Suarez-Lledo, Alvaro Urbano-Ispizua, Carmen Martinez, MD PhD

Blood (2015) 126 (23): 5464.

https://doi.org/10.1182/blood.V126.23.5464.5464

Published: 2015

Journal Articles

Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH)

Blood (2015) 126 (23): 4399.

https://doi.org/10.1182/blood.V126.23.4399.4399

Published: 2015

Journal Articles

Piwirna-651 Expression Influences Treatment Response and Impacts Survival in Classical Hodgkin Lymphoma Patients through Regulation of ABCC5

Alfons Navarro, PhD, Anna Cordeiro, Msc, Anna Gaya, MD, Blanca Gonzalez-Farre, MD, Marina Díaz-Beyá, MD PhD, Dolors Fuster, Carmen Martínez, MD, Jordi Esteve, MD PhD, Antonio Martinez, MD, Mariano Monzó, MD PhD

Blood (2014) 124 (21): 134.

https://doi.org/10.1182/blood.V124.21.134.134

Published: 2014

Journal Articles

Allogeneic Stem-Sell Transplantation In Multiple Myeloma In Real Practice: Long-Term Results From a Single Institution

Raquel Jiménez, MD, Laura Rosiñol, MD, Montserrat Rovira, MD, Francisco Fernández-Avilés, Carmen Martínez, MD, Gonzalo Gutiérrez-García, Maria Suárez-LLedó, Carlos Fernández De Larrea, MD, Alvaro Urbano, MD, Joan Blade, MD

Blood (2013) 122 (21): 5524.

https://doi.org/10.1182/blood.V122.21.5524.5524

Published: 2013

Journal Articles

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Reduced Intensity Conditioning (RIC) Regimens and High Dose Cylophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In Patients With Relapsed Or Refractory Hodgkin´s Disease: Multicentric Spanish Experience

Jorge Gayoso, MD, Pascual Balsalobre, MSc, Cristina Castilla-Llorente, MD, María Jesús Pascual, MD, Mi Kwon, MD, David Serrano, MD, Dolores Caballero, MD, PhD, Jose Antonio Pérez-Simón, Arancha Bermudez, MD, Carmen Martínez, MD, Cristina Pascual, MD, Inmaculada Heras, Carlos Solano, Angela Figuera, MD, Antonia Sampol, MD, PhD, Christelle Ferra, MD, Pilar Herrera, Ismael Buno, PhD, Jose Luis Diez-Martin, MD, PhD

Blood (2013) 122 (21): 3406.

https://doi.org/10.1182/blood.V122.21.3406.3406

Published: 2013

Journal Articles

Salvage Treatment with Ofatumumab and ESHAP (O-ESHAP) for Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma After First-Line Chemotherapy: Interim Analysis of a Phase II Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Carmen Martinez, MD, Mercedes Rodriguez-Calvillo, María José Terol, MD, PhD, Blanca Xicoy, MD, PhD, Ramón García-Sanz, Elena Perez-Ceballos, Alberto Cantalapiedra, Eva Domingo-Domènech, MD, Miguel Hernández, Antonia Sampol, MD, Manuel Espeso, Javier Briones, MD, Javier Lopez, Anna Sureda, MD

Blood (2012) 120 (21): 1630.

https://doi.org/10.1182/blood.V120.21.1630.1630

Published: 2012

Journal Articles

A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

Beatriz Martin-Antonio, Ph.D., Maria Suarez-LLedo, Montserrat Arroyes, Francesc Fernandez-Avilés, Carmen Martinez, MD, Montserrat Rovira, Ildefonso Espigado, MD, PhD, David Gallardo, MD, PhD, Anna Bosch, Ismael Buno, PhD, Carolina Martinez-Laperche, PhD, Antonio Jimenez-Velasco, Rafael De La Camara, MD, Salut Brunet, Jose B. Nieto, Alvaro Urbano-Ispizua, MD/Ph.D

Blood (2012) 120 (21): 468.

https://doi.org/10.1182/blood.V120.21.468.468

Published: 2012

Journal Articles

Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT

Blood (2011) 118 (21): 3056.

https://doi.org/10.1182/blood.V118.21.3056.3056

Published: 2011

Journal Articles

The Combination of Siromilus Plus Tacrolimus (SiTac) Improves the Results of Cyclosporine Plus Mycophenolate Mofetil (CsAMMF) After Reduced Intensity Conditioning (RIC) Unrelated Donor Allogeneic Transplantation

Jose Antonio Perez-Simón, Sr., MD, PhD, Rodrigo Martino, MD, PhD, Rocio Parody, MD, M. Cabrero, Lucía López-Corral, David Valcarcel, MD, Carmen Martinez, MD, Carlos Solano, Rafael De La Camara, MD, Inmaculada Heras, Dolores Caballero, MD, Jordi Sierra, MD, PhD

Blood (2011) 118 (21): 890.

https://doi.org/10.1182/blood.V118.21.890.890

Published: 2011

Journal Articles

A Recessive Gene Variant in TGFB1 in the Donor Influences the Acute Graft Versus Host Disease Development and Impacts in the Outcome After Allogeneic Stem Cell Transplantation (Allo-SCT),

Beatriz Martin-Antonio, Damià Romero, Ildefonso Espigado, MD, PhD, David Gallardo, MD, PhD, Anna Bosch, Ismael Buno, Carolina Martinez-Laperche, Antonio Jimenz-Velasco, Rafael De La Camara, MD, Salut Brunet, Jose B Nieto, Jose Román, Maria Suarez-LLedo, Francesc Fernandez-Avilés, Carmen Martinez, MD, Montserrat Rovira, Alvaro Urbano-Ispizua, MD

Blood (2011) 118 (21): 4080.

https://doi.org/10.1182/blood.V118.21.4080.4080

Published: 2011

Journal Articles

Immune Status In Patients with Chronic Lymphocytic Leukemia and Sustained Complete Remission: A Multiparametric Analysis

Kate E Hodgson, MD, Gerardo Ferrer, Carmen Martinez, MD, Manel Juan, Tycho Baumann, MD, Montserrat Rovira, MD, Marta Aymerich, Laura Carretero, Francesc Bosch, MD, Alvaro Urbano, MD, Emili Montserrat, MD, Carol Moreno, MD, PhD

Blood (2010) 116 (21): 1389.

https://doi.org/10.1182/blood.V116.21.1389.1389

Published: 2010

Journal Articles

Regulation of Jak2 Kinase Gene by the Mir-135 Family in Classical Hodgkin Lymphoma

Alfons Navarro, PhD, Tania Diaz, Antonio Martinez, MD, PhD, Anna Gaya, MD, Aina Pons, Carmen Martinez, MD, Emili Montserrat, MD, PhD, Mariano Monzo, MD, PhD

Blood (2008) 112 (11): 518.

https://doi.org/10.1182/blood.V112.11.518.518

Published: 2008

Journal Articles

Analysis of microRNA Patterns in Hodgkin’s Lymphoma (HL).

Alfons Navarro, PhD, Anna Gaya, MD, Aina Pons, PhD, Pau Abrisqueta, MD, Bernat Gel, PhD, Antonio Martinez, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Carmen Martinez, MD, PhD, Miquel Granell, MD, Rosa Artells, PhD, Sonia Jansa, PhD, Alvaro Urbano-Ispizua, MD, PhD, Emili Montserrat, MD, PhD, Mariano Monzo, MD, PhD

Blood (2006) 108 (11): 474.

https://doi.org/10.1182/blood.V108.11.474.474

Published: 2006

Journal Articles

Donor’s Mannan-Binding Lectin (MBL) Gene Polymorphism Is Associated with Invasive Fungal Infection Following Allogeneic Stem Cell Transplantation.

Miquel Granell, MD, Alvaro Urbano-Ispizua, MD, Francisco Lozano, MD, Montserrat Rovira, MD, Francesc Fernandez-Aviles, MD, Mar Ortega, MD, Carla Uriburu, MD, Carme Talarn, MD, Carmen Martinez, MD, Belen Suarez, Anna Guardia, MD, Enric Carreras, MD, Emili Montserrat, MD

Blood (2004) 104 (11): 2220.

https://doi.org/10.1182/blood.V104.11.2220.2220

Published: 2004

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Evolution of Outcome over Time for Relapsed Hodgkin Lymphoma after Autologous Stem Cell Transplant: Improved Survival for Early Relapse in Recent Years

Post-Transplant High-Dose Cyclophosphamide Overcomes the Detrimental Effect of a Single-Locus HLA Mismatched in Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

Second Autologous Stem Cell Transplantation for Relapsed or Refractory Hodgkin Lymphoma after a Previous Autograft: A Registry Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Evaluation of the Regimen Brentuximab Vedotin Plus ESHAP (BRESHAP) in Refractory or Relapsed Hodgkin Lymphoma Patients: Preliminary Results of a Phase I-II Trial from the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Association Between Uric Acid Levels and Severe Acute Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation

Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH)

Piwirna-651 Expression Influences Treatment Response and Impacts Survival in Classical Hodgkin Lymphoma Patients through Regulation of ABCC5

Allogeneic Stem-Sell Transplantation In Multiple Myeloma In Real Practice: Long-Term Results From a Single Institution

Haploidentical Stem Cell Transplantation (HAPLO-HSCT) With Reduced Intensity Conditioning (RIC) Regimens and High Dose Cylophosphamide Post-Transplant (HD-CY) As Gvhd Prophylaxis In Patients With Relapsed Or Refractory Hodgkin´s Disease: Multicentric Spanish Experience

Salvage Treatment with Ofatumumab and ESHAP (O-ESHAP) for Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma After First-Line Chemotherapy: Interim Analysis of a Phase II Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

Outcome of Second Allogeneic SCT Following Relapse of Hematological Malignancies After a First Allogeneic SCT

The Combination of Siromilus Plus Tacrolimus (SiTac) Improves the Results of Cyclosporine Plus Mycophenolate Mofetil (CsAMMF) After Reduced Intensity Conditioning (RIC) Unrelated Donor Allogeneic Transplantation

A Recessive Gene Variant in TGFB1 in the Donor Influences the Acute Graft Versus Host Disease Development and Impacts in the Outcome After Allogeneic Stem Cell Transplantation (Allo-SCT),

Immune Status In Patients with Chronic Lymphocytic Leukemia and Sustained Complete Remission: A Multiparametric Analysis

Regulation of Jak2 Kinase Gene by the Mir-135 Family in Classical Hodgkin Lymphoma

Analysis of microRNA Patterns in Hodgkin’s Lymphoma (HL).

Donor’s Mannan-Binding Lectin (MBL) Gene Polymorphism Is Associated with Invasive Fungal Infection Following Allogeneic Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only